These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8248092)

  • 1. Molecular dynamics of the 5-HT1a receptor and ligands.
    Sylte I; Edvardsen O; Dahl SG
    Protein Eng; 1993 Sep; 6(7):691-700. PubMed ID: 8248092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor.
    Edvardsen O; Sylte I; Dahl SG
    Brain Res Mol Brain Res; 1992 Jul; 14(3):166-78. PubMed ID: 1331649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
    Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
    J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
    Homan EJ; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
    Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
    Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics of dopamine at the D2 receptor.
    Dahl SG; Edvardsen O; Sylte I
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8111-5. PubMed ID: 1910173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of antipsychotic drugs and G protein coupled receptors.
    Dahl SG; Edvardsen O; Sylte I
    Therapie; 1991; 46(6):453-9. PubMed ID: 1819151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor.
    Grånäs C; Larhammar D
    Eur J Pharmacol; 1999 Sep; 380(2-3):171-81. PubMed ID: 10513577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of the endogenous peptide Leu-Ser-Ala-Leu, pindolol, 5-hydroxytryptamine and their interactions with the human 5-hydroxytryptamine1B (5-HT1B) receptor.
    Kristiansen K; Edvardsen O; Dahl SG
    Recept Channels; 1998; 6(1):31-50. PubMed ID: 9664621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding site.
    Gready JE; Ranganathan S; Schofield PR; Matsuo Y; Nishikawa K
    Protein Sci; 1997 May; 6(5):983-98. PubMed ID: 9144769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine(1a) receptor ligands to explore the three-dimensional structure of the receptor.
    López-Rodríguez ML; Vicente B; Deupi X; Barrondo S; Olivella M; Morcillo MJ; Behamú B; Ballesteros JA; Sallés J; Pardo L
    Mol Pharmacol; 2002 Jul; 62(1):15-21. PubMed ID: 12065750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between a negatively charged ligand and the electronegative binding pocket of its receptor.
    Huang HC; Briggs JM
    Biopolymers; 2002 Apr; 63(4):247-60. PubMed ID: 11807752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.
    Bronowska A; Leś A; Chilmonczyk Z; Filipek S; Edvardsen O; Ostensen R; Sylte I
    Bioorg Med Chem; 2001 Apr; 9(4):881-95. PubMed ID: 11354671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor.
    Luo X; Zhang D; Weinstein H
    Protein Eng; 1994 Dec; 7(12):1441-8. PubMed ID: 7716154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling of UH-301 and 5-HT(1a) receptor interactions.
    Sylte I; Edvardsen O; Dahl SG
    Protein Eng; 1996 Feb; 9(2):149-60. PubMed ID: 9005436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Fernández E; Schaper KJ
    J Med Chem; 1997 May; 40(11):1648-56. PubMed ID: 9171874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions.
    Kristiansen K; Dahl SG
    Eur J Pharmacol; 1996 Jun; 306(1-3):195-210. PubMed ID: 8813633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the structural and mechanistic basis of function, classification, and ligand design for 5-HT receptors.
    Weinstein H; Osman R
    Neuropsychopharmacology; 1990; 3(5-6):397-409. PubMed ID: 2078275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
    Kuipers W; Van Wijngaarden I; Ijzerman AP
    Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular structure and dynamics of serotonin.
    Edvardsen O; Dahl SG
    Brain Res Mol Brain Res; 1991 Jan; 9(1-2):31-7. PubMed ID: 1850076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.